The clinical stage pharmaceutical company specializes in creating small molecule new chemical entities to treat autoimmune and inflammatory diseases such as hidradenitis suppurativa (HS) and ulcerative colitis (UC), aiming to provide patients with better treatment options. Azora Therapeutics' therapeutic medicine is intended to alleviate the debilitating effects of these diseases, with the goal of improving patients' quality of life.